跳至主要内容
临床试验/NCT07245628
NCT07245628招募中1 期

A Single-Blind Randomized Placebo Controlled Trial of Self-Adjusted Nitrous Oxide During Office Vasectomy

Alexandra J. Berger Eberhardt, MD1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年10月20日最近更新:
干预措施

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
50
试验地点
1
主要终点
Mean Difference in VAS-A During Vasectomy Procedure and S-PCS Immediately After Vasectomy Procedure, Comparing Participants Receiving and Not Receiving Self-Administered Low Dose Nitrous Oxide

研究概览

简要总结

The goal of this clinical trial is to see if nitrous oxide is safe and effective to use during during vasectomies performed in a clinic/in-office setting.

This trial will compare self-administered nitrous oxide versus a placebo (oxygen) during office vasectomy.

The main questions it aims to answer are:

  • Whether self-administered low dose (20-45%) nitrous oxide (SANO) reduces intraoperative anxiety and catastrophizing during office vasectomy.
  • To examine whether SANO reduces intraoperative pain or alters procedure duration, the rate of adverse events, or urologists' perception of ease and patient tolerance of the procedure.

Participants will be asked to complete multiple surveys pre-procedure, intra-procedure, and post-procedure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Age 18 - 85 at the time of screening
  • Desiring vasectomy for family planning purposes
  • Able to understand and complete patient questionnaires
  • Willing and able to provide written consent to participate in the study

排除标准

  • Patients with unilateral absence of the vas deferens
  • Patients who are deemed by study surgeons to have anatomy no amendable for office procedure
  • Patients who decline office vasectomy and request monitored anesthesia care
  • Patients taking benzodiazepine or narcotic medication daily or within 24 hours of the procedure
  • Patients with contraindications to nitrous oxide including:
  • Inner ear, bariatric, or eye surgery within the past 2 weeks
  • Current emphysematous blebs
  • Severe B-12 deficiency
  • History of bleomycin chemotherapy within the last year
  • Class III or higher heart failure

研究组 & 干预措施

Placebo (Oxygen)

Placebo Comparator

Self-Administered Placebo (Oxygen)

干预措施: Oxygen (Drug)

Nitrous Oxide

Experimental

Self-Administered Nitrous Oxide

干预措施: Nitrous Oxide (Drug)

结局指标

主要结局

Mean Difference in VAS-A During Vasectomy Procedure and S-PCS Immediately After Vasectomy Procedure, Comparing Participants Receiving and Not Receiving Self-Administered Low Dose Nitrous Oxide

时间窗: Intra-Procedure (Immediately After Injection of Local Anesthesia) - Post-Procedure (10 Minutes After Procedure Completion, Allow for Nitrous Oxide to be Metabolized)

Measuring the mean difference in Visual Analog Scale for Anxiety (VAS-A) during the vasectomy procedure and the Situational Pain Catastrophizing Scale (S-PCS) immediately after the vasectomy procedure, comparing those receiving and not receiving self-administered low dose nitrous oxide. Intra-Procedure (Immediately After Injection of Local Anesthesia) Visual Analog Scale for Anxiety (VAS-A) (Zero is equivalent to no anxiety and 10 indicates the worst anxiety) Intra-Procedure (In Between Left and Right Sides of Procedure) Visual Analog Scale for Anxiety (VAS-A) (Zero is equivalent to no anxiety and 10 indicates the worst anxiety) Post-Procedure (10 Minutes After Procedure Completion, to Allow for Nitrous Oxide to be Metabolized) 1. Situational Pain Catastrophizing Scale (S-PCS) (Zero is equivalent to not at all and 4 indicates all the time) 2. Visual Analog Scale for Anxiety (VAS-A) (Zero is equivalent to no anxiety and 10 indicates the worst anxiety)

次要结局

  • Mean Difference in Visual Analog Scale for Pain (VAS-P) Intra-Procedurally, Comparing Participants Receiving and Not Receiving Self-Administered Low Dose Nitrous Oxide(Intra-Procedure (Immediately After Injection of Local Anesthesia) - Intra-Procedure (In Between Left and Right Sides of Procedure))
  • Mean Difference in VAS-P and STAI Pre- and Post-Procedurally, Comparing Participants Receiving and Not Receiving Self-Administered Low Dose Nitrous Oxide(Pre-Procedure (Day of Procedure, Immediately Prior) - Post-Procedure (10 Minutes After Procedure Completion, Allow for Nitrous Oxide to be Metabolized))
  • Mean Difference in 30-Day Complications / Adverse Events, Comparing Participants Receiving and Not Receiving Self-Administered Low Dose Nitrous Oxide(Study Enrollment - 30 Days After Vasectomy)
  • Urologist: Ease of Procedure, Comparing Participants Receiving and Not Receiving Self-Administered Low Dose Nitrous Oxide(Post-Procedure, Day of Vasectomy)
  • Urologist: Patient Tolerance, Comparing Participants Receiving and Not Receiving Self-Administered Low Dose Nitrous Oxide(Post-Procedure, Day of Vasectomy)
  • Mean Difference in Duration of Procedure, Comparing Participants Receiving and Not Receiving Self-Administered Low Dose Nitrous Oxide(Intra-Procedure (Immediately After Injection of Local Anesthesia) - Post-Procedure (10 Minutes After Procedure Completion, Allow for Nitrous Oxide to be Metabolized))

研究者

发起方
Alexandra J. Berger Eberhardt, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Alexandra J. Berger Eberhardt, MD

Associate Surgeon, Department of Urology, Brigham and Women's Hospital; Assistant Professor, Harvard Medical School

Brigham and Women's Hospital

研究点 (1)

Loading locations...

相似试验

A Trial of Self-Adjusted Nitrous Versus Placebo... | 临床试验